Type 1 Diabetes - Pathogenesis, Genetics and Immunotherapy 2011
DOI: 10.5772/22283
|View full text |Cite
|
Sign up to set email alerts
|

Beta Cell Replacement Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…T1D requires life-long insulin therapy; however, several complications are associated with insulin injections, including hypoglycemic events and the persistence of macrovascular complications [ 2 , 3 ]. Therefore, beta cell replacement therapy is a promising treatment for T1D [ 4 ]. However, the success of this strategy is affected by a decrease in cell mass due to mechanical stress, a lack of oxygen, vascularization, an immediate blood-mediated immune response (IBMIR), and a lack of islet availability [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…T1D requires life-long insulin therapy; however, several complications are associated with insulin injections, including hypoglycemic events and the persistence of macrovascular complications [ 2 , 3 ]. Therefore, beta cell replacement therapy is a promising treatment for T1D [ 4 ]. However, the success of this strategy is affected by a decrease in cell mass due to mechanical stress, a lack of oxygen, vascularization, an immediate blood-mediated immune response (IBMIR), and a lack of islet availability [ 5 ].…”
Section: Introductionmentioning
confidence: 99%